ALK and small cell lung carcinoma: ALK gene rearrangement examination, diagnosis by a multi-disciplinary team including respiratory physicians, neurologists, pathologists, and genetic testing specialists, and proactive treatments including ALK inhibitors may be considered in the future for estimating the prognosis of SCLC patients.